155(top 1%)
papers
3.3K(top 1%)
citations
33(top 1%)
h-index
52(top 1%)
g-index
164
all documents
3.7K
doc citations
829
citing journals

Top Articles

#TitleJournalYearCitations
1A Multi‐institutional, Prospective, Phase II Feasibility Study of Laparoscopy‐Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901)World Journal of Surgery2015237
2Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studiesNature Medicine2020209
3CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast CancerInternational Journal of Molecular Sciences2020118
4The long-term survival of stage IV gastric cancer patients with conversion therapyGastric Cancer2018111
5M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancerScientific Reports2020109
6Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of JapanInternational Journal of Clinical Oncology2015102
7G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast CancerInternational Journal of Molecular Sciences2020100
8JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusionsAnnals of Oncology202094
9Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in JapanGastric Cancer201988
10Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort studyGastric Cancer201883
11The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast CancerCells202076
12Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trialThe Lancet Gastroenterology and Hepatology201973
13Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast CancerCancers202066
14Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II studyGastric Cancer201763
15Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)Cancers202062
16Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast CancerInternational Journal of Molecular Sciences202056
17Morbidity and mortality from a propensity score-matched, prospective cohort study of laparoscopic versus open total gastrectomy for gastric cancer: data from a nationwide web-based databaseSurgical Endoscopy and Other Interventional Techniques201854
18KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survivalAmerican Journal of Cancer Research202054
19Surgical outcomes of laparoscopic distal gastrectomy compared to open distal gastrectomy: A retrospective cohort study based on a nationwide registry database in JapanAnnals of Gastroenterological Surgery201851
20Urine as a Source of Liquid Biopsy for CancerCancers202150
21Association of circulating tumor DNA dynamics with clinical outcomes in the adjuvant setting for patients with colorectal cancer from an observational GALAXY study in CIRCULATE-Japan.Journal of Clinical Oncology202248
22Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global WebinarsJCO Global Oncology202044
23Risk and early predictive factors of anastomotic leakage in laparoscopic low anterior resection for rectal cancerWorld Journal of Surgical Oncology201942
24The Roles of Surgical Oncologists in the New Era – Minimally Invasive Surgery for Early Gastric Cancer and Adjuvant Surgery for Metastatic Gastric CancerPathobiology201141
25High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) ResectionCancers202041
26Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast CancerCancers202041
27Overexpression of KIF11 in Gastric Cancer with Intestinal Mucin PhenotypePathobiology201740
28KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer CellsAnticancer Research201740
29Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell ProliferationInternational Journal of Molecular Sciences202039
30High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast CancerInternational Journal of Molecular Sciences202038
31Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC)Cancers202136
32Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric CancerAnnals of Surgical Oncology201435
33Recent advancements in esophageal cancer treatment in JapanAnnals of Gastroenterological Surgery201835
34High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast CancerInternational Journal of Molecular Sciences202035
35Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer PatientsJournal of Immunology Research202034
36Induction of KIFC1 expression in gastric cancer spheroidsOncology Reports201633
37ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast CancerCancers202033
38Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07Gastric Cancer202233
39Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 GastrectomyAnnals of Surgical Oncology201932
40High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast CancerCancers202032
41Surgeons have knowledge gaps in the safe use of energy devices: a multicenter cross-sectional studySurgical Endoscopy and Other Interventional Techniques201631
42Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trialThe Lancet Gastroenterology and Hepatology202131
43Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08British Journal of Cancer202030
44Rapamycin enhances chemotherapy‐induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cellsInternational Journal of Cancer201028
45Surgical risk and benefits of laparoscopic surgery for elderly patients with gastric cancer: a multicenter prospective cohort studyGastric Cancer201928
46MicroRNA‐143/Musashi‐2/KRAS cascade contributes positively to carcinogenesis in human bladder cancerCancer Science201927
47Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic CancerCells202127
48Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric CancerClinical Cancer Research202127
49Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)European Journal of Cancer201525
50Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survivalScientific Reports202125